Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
AUTOR(ES)
Jones, R N
RESUMO
The in vitro activity of cefoperazone (T-1551) against almost 9,000 recent clinical isolates at six institutions was tested and compared with that of cephalothin and gentamicin. The modal minimum inhibitory concentrations of cefoperazone were 16- and 4-fold less than those of cephalothin and gentamicin, respectively, against 5,503 strains of Enterobacteriaceae. Species normally resistant to cephalothin, such as indole-positive protease and enterobacters, were almost universally susceptible to cefoperazone. Cefoperazone demonstrated activity comparable to gentamicin against Pseudomonas aeruginosa and other pseudomonads.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=283865Documentos Relacionados
- In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.
- Cefuroxime, a New Parenteral Cephalosporin: Collaborative In Vitro Susceptibility Comparison with Cephalothin Against 5,887 Clinical Bacterial Isolates
- Comparison of Cefazolin, a New Cephalosporin Antibiotic, with Cephalothin
- HR 756, a Highly Active Cephalosporin: Comparison with Cefazolin and Carbenicillin
- Cefazaflur, a New Parenteral Cephalosporin: In Vitro Studies